Urology Renal Medicine B
Renal Stone Risk Assessment
Clinical risk stratification for renal/ureteric stone recurrence to guide metabolic workup and prevention.
References
- EAU Guidelines on Urolithiasis. European Association of Urology. 2023.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
Drugs
- Allopurinol · Xanthine Oxidase Inhibitor — Uric Acid Stone Prevention
- Diclofenac · NSAID — Renal / Ureteric Colic
- Anethol with Borneol, Camphene, Cineole, Fenchone and Pinene · Terpene Mixture (Urolithiasis / Renal Colic)
- Icosapent Ethyl (Omega-3 — Cardiovascular Risk Reduction) · Omega-3 Fatty Acid (Purified EPA — Eicosapentaenoic Acid Ethyl Ester)
- Noradrenaline (Norepinephrine) · Vasopressor (Alpha-1 and Beta-1 Agonist)
- Tranexamic Acid (ICU/Trauma/Surgical) · Antifibrinolytic
Decision support only — verify against MDCalc, NICE, or your local guideline before clinical use.